Lucid Diagnostics Inc. (LUCD) Reports In-Line Q1 EPS

Lucid Diagnostics Inc. (NASDAQ: LUCD) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $1.26 million versus the consensus estimate of $1.38 million.

For earnings history and earnings-related data on Lucid Diagnostics Inc. (LUCD) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• PreveCeutical closes second tranche of private placement for $245,000
• Super League Enterprise (SLE) files for 1.07M share offering by selling stockholders